Executive Medical Director, Clinical Development, Breast Cancer
United States · Remote OK
$300k–$400k/yr
Senior+
Overview The Executive Medical Director, Clinical Development, Solid Tumors will be responsible for driving the global clinical development strategy in solid tumors, specifically Stemline’s Breast Cancer product, Elacest…
Skills: Clinical development, Oncology, Breast cancer research, Medical monitoring, Clinical study protocols
Overview The Executive Director, Clinical Assessment & Evaluation is a physician responsible for supporting business development opportunities at pre-clinical and clinical stages, tasked with translating pre-clinical and…
Skills: Oncology, Clinical development, Business development, Due diligence, Regulatory approval
Medical Director, Clinical Development, Hematologic Malignancies
New York, United States · Remote OK
$289k–$342k/yr
Senior
Overview The Medical Director, Clinical Development, Hematologic Malignancies will serve as a Medical Monitor for post-marketing studies. This is a critical, hands-on role requiring deep expertise in hematologic malignan…
Oncology Territory Manager, Solid Tumor (Chicago North, IL)
Illinois, United States · On-site
$180k–$220k/yr
Senior
Overview Menarini Stemline is hiring a Territory Manager, Breast Cancer/Solid Tumor. The Territory Manager is responsible for the sale and support of Stemline products to both existing and potential customers. The goals …
Overview Menarini Stemline is hiring a (Sr) Medical Science Liaison for (Plains) . The Medical Science Liaison (MSL) will be responsible for the scientific exchange of Stemline’s pipeline, disease state awareness and gen…
Skills: Medical Science Liaison, Solid Tumor Oncology, Breast Medical Oncology, KOL Relationship Management, Clinical Research Support
Overview This is a foundational role in the expansion of the US Oncology marketing team for the hematology and solid tumor therapeutic areas. The Director will assume a key role responsible for a multitude of External Ex…
Overview The Global Clinical Program Lead is as matrix leader of a cross-functional Clinical Program Team responsible for the operation for assigned clinical program(s). Key accountabilities include developing and implem…
Director, Clinical Development Lead, Hematologic Malignancies
New York, New York, United States · Remote OK
$280k–$340k/yr
Senior
Overview The Medical Director, Clinical Development Lead, Hematology will lead the clinical direction, planning, execution, and interpretation of clinical trials of one or more Heme-oncology clinical development programs…
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
$300k–$400k/yr
Full-time
postgraduate degree
401(k) with company match, Anthem Premier PPO insurance, HDHP insurance, Company paid Basic Life insurance, AD&D insurance, Pre-tax FSA program
Posted 75d ago
Apply by May 28
~40 hrs/week
Remote in United States
Responsibilities
The Executive Medical Director will lead the global clinical development strategy for solid tumors, specifically focusing on the breast cancer product Elacestrant. Responsibilities include overseeing Phase 1-4 clinical studies, managing multi-disciplinary teams, and ensuring successful regulatory submissions.
Requirements
Candidates must hold a Medical Degree with over 12 years of experience in the pharmaceutical or biotech industry, with a strong preference for board-certified oncologists. Expertise in clinical trial strategy, regulatory compliance, and leadership within oncology development programs is required.
Full job description
Overview
The Executive Medical Director, Clinical Development, Solid Tumors will be responsible for driving the global clinical development strategy in solid tumors, specifically Stemline’s Breast Cancer product, Elacestrant. The incumbent will be responsible for providing critical input into the strategy, development, management, and implementation of Phase 1-4 clinical studies including a registration-enabling Phase 3 study, by closely working with the Clin Ops colleagues; leading multi-disciplinary teams charged with guiding clinical development and subsequent regulatory submissions.
Responsibilities
Represent the clinical line function on global program team(s) and contribute to strategic planning and execution of clinical development plan for the assigned assets being developed in solid tumors.
Lead the development of clinical study protocols, protocol amendments, study guides, protocol training materials and other clinical study related documents based on the global development plan.
Perform medical monitoring (safety data review and identify potential signals), responses to site inquiries, and work with CRO medical monitors when appropriate.
Take medical responsibility in data analysis and interpretation, reporting and communication to ensure consistency and relevance of medical content and scientific messages across Clinical Study Report, health authority briefing books, and NDA/BLA submission documents, etc.
Contribute to operational aspects of study conduct and patient enrolment efforts including participation in site training, initiation and activation and subsequent site engagement activities.
Maintain focus on robust study conduct and quality data generation.
Demonstrate the ability to develop unique and innovative clinical strategies to significantly shorten the development cycle in the face of an evolving regulatory landscape.
Responsible for phase I – IV clinical development of products. Primary focus includes a pivotal Phase 3 trial.
May oversee the work of Medical and/or Scientific Directors and of Clinical Scientists working on the same or related programs.
Qualifications
Medical Degree with 12+ years pharma/biotech experience.
Board certified oncologist and/or training in oncology is strongly preferred.
Training in Breast Cancer and/or experience developing Breast Cancer compounds in the industry is strongly preferred.
Experience developing clinical strategy for oncology products (Phase I-IV) leading to successful regulatory submission(s) is required.
Recognized expert in clinical trials: understanding of statistical principles, medical monitoring; demonstrated ability to perform literature research, analyses, and author clinical trial publications.
Working knowledge of GCP, ICH, FDA, and EMEA regulations.
Excellent and effective written and verbal communication skills with all levels of the organization.
Ability to work cross-functionally, partners with oncology development functions such as: Operations, Regulatory, Medical Affairs, Statistics, PK/PD and others such as commercial and/or HEOR or other functions as required,
Experience communicating and interacting with investigators, KOLs, regulatory agencies, and advisors.
Experience working with the principles and techniques of data analysis, interpretation, and clinical relevance.
Solid knowledge of compliance and global regulatory requirements (ICH) for development of pharmaceutical candidates/products (required).
Proven ability to represent the Company’s interest effectively in interactions with partners and regulatory agencies.
Acts as clinical lead and actively solicits opinion leader interactions related to the disease area(s)
Ability to lead a dynamic group in a fast-paced and hands-on environment.
Excellent scientific standing among peers and the ability to address issues with scientific rigor and creative solutions.
Ability to develop and implement strategic growth plans.
Prior leadership experience preferred.
Comfortable with ambiguity yet be self-motivated and timeline driven.
Please note: This is a remote base position but is classified as a corporate office position. In accordance with the New York state employer convenience rule, Stemline will withhold New York state income taxes for all corporate office employees, regardless of whether these employees work in New York or remotely.
Base Salary Range of $300,000 - $400,000 plus annual bonus & long-term Incentives.. Menarini Stemline offers generous compensation and benefits packages, including, Fidelity 401(k) (with company match), Anthem Premier PPO and HDHP insurance plans, Company paid Basic Life & AD&D insurance and pre-tax FSA/HSA programs.
Menarini Stemline is committed to creating an inclusive environment for all employees. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran. Reasonable accommodations may be made to enable qualified individuals with disabilities to perform the essential functions.
#LI-PR1
Related keywords
Clinical DevelopmentOncologyBreast CancerElacestrantPhase 3 TrialMedical MonitoringRegulatory SubmissionNDABLAGCPICHFDAEMEAClinical Study ReportKOLBiotech
The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees.
With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics.
The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world.
For further information, please visit www.menarini.com
For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group
For reading our Privacy Notice for social networks users, please
visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
Offices: Via dei Sette Santi 1/3, Firenze, Italy 50131, IT
ALLERGOLOGYANDROLOGYANTINFECTIVE AREACARDIOVASCULAR AREASGASTROINTESTINAL DISORDERSGYNECOLOGY AND WOMEN'S WELLNESSPAINTRAUMA AND HEADACHESRESPIRATORY AREAREUMATOLOGY
The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees.
With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics.
The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world.
For further information, please visit www.menarini.com
For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group
For reading our Privacy Notice for social networks users, please
visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
Offices: Via dei Sette Santi 1/3, Firenze, Italy 50131, IT
ALLERGOLOGYANDROLOGYANTINFECTIVE AREACARDIOVASCULAR AREASGASTROINTESTINAL DISORDERSGYNECOLOGY AND WOMEN'S WELLNESSPAINTRAUMA AND HEADACHESRESPIRATORY AREAREUMATOLOGY